{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:52:53Z","timestamp":1768708373652,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","award":["FRD #10.03"],"award-info":[{"award-number":["FRD #10.03"]}],"id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA077598"],"award-info":[{"award-number":["P30 CA077598"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1T32 CA009138-31s"],"award-info":[{"award-number":["1T32 CA009138-31s"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00262-015-1749-6","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T09:30:48Z","timestamp":1438853448000},"page":"1449-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment"],"prefix":"10.1007","volume":"64","author":[{"given":"Jaime F.","family":"Modiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Lindborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron T.","family":"McElmurry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitzi","family":"Lewellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen L.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Schaack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Bellgrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"1749_CR1","unstructured":"Modiano JF, Lamerato-Kozicki AR, Jubala CM, Coffey D, Borakove M, Schaack J, Bellgrau D (2004) Fas ligand gene transfer for cancer therapy. Cancer Ther. 2: 561\u2013570. http:\/\/cancer-therapy.org\/CT\/v2\/A\/59.%20Modiano%20et%20al,%20561-570.pdf"},{"key":"1749_CR2","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1038\/mt.2012.149","volume":"20","author":"JF Modiano","year":"2012","unstructured":"Modiano JF, Bellgrau D, Cutter GR et al (2012) Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. Mol Ther 20:2234\u20132243. doi: 10.1038\/mt.2012.149","journal-title":"Mol Ther"},{"key":"1749_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ijc.23474","volume":"123","author":"MY Ho","year":"2008","unstructured":"Ho MY, Sun GH, Leu SJ, Ka SM, Tang SJ, Sun KH (2008) Combination of fasl and gm-csf confers synergistic antitumor immunity in an in vivo model of the murine lewis lung carcinoma. Int J Cancer 123:123\u2013133. doi: 10.1002\/ijc.23474","journal-title":"Int J Cancer"},{"key":"1749_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/sj.cgt.7700965","volume":"13","author":"JS Norris","year":"2006","unstructured":"Norris JS, Bielawska A, Day T et al (2006) Combined therapeutic use of adgfpfasl and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Ther 13:1045\u20131051. doi: 10.1038\/sj.cgt.7700965","journal-title":"Cancer Gene Ther"},{"key":"1749_CR5","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.4049\/jimmunol.162.12.7350","volume":"162","author":"M Shimizu","year":"1999","unstructured":"Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A (1999) Induction of antitumor immunity with fas\/apo-1 ligand (cd95l)-transfected neuroblastoma neuro-2a cells. J Immunol. 162:7350\u20137357","journal-title":"J Immunol."},{"key":"1749_CR6","doi-asserted-by":"publisher","first-page":"13862","DOI":"10.1073\/pnas.94.25.13862","volume":"94","author":"H Arai","year":"1997","unstructured":"Arai H, Gordon D, Nabel EG, Nabel GJ (1997) Gene transfer of fas ligand induces tumor regression in vivo. Proc Natl Acad Sci U S A 94:13862\u201313867","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1749_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nm0297-165","volume":"3","author":"K Seino","year":"1997","unstructured":"Seino K, Kayagaki N, Okumura K, Yagita H (1997) Antitumor effect of locally produced cd95 ligand. Nat Med 3:165\u2013170","journal-title":"Nat Med"},{"key":"1749_CR8","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.4049\/jimmunol.167.11.6217","volume":"167","author":"AM Hohlbaum","year":"2001","unstructured":"Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A (2001) Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 167:6217\u20136224","journal-title":"J Immunol"},{"key":"1749_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00262-008-0535-0","volume":"58","author":"CM Jubala","year":"2009","unstructured":"Jubala CM, Lamerato-Kozicki AR, Borakove M et al (2009) Mhc-dependent desensitization of intrinsic anti-self reactivity. Cancer Immunol Immunother 58:171\u2013185. doi: 10.1007\/s00262-008-0535-0","journal-title":"Cancer Immunol Immunother"},{"key":"1749_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cytogfr.2007.10.007","volume":"19","author":"A Le Bon","year":"2008","unstructured":"Le Bon A, Tough DF (2008) Type i interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev 19:33\u201340. doi: 10.1016\/j.cytogfr.2007.10.007","journal-title":"Cytokine Growth Factor Rev"},{"key":"1749_CR11","doi-asserted-by":"publisher","first-page":"e26403","DOI":"10.4161\/onci.26403","volume":"2","author":"L Spel","year":"2013","unstructured":"Spel L, Boelens JJ, Nierkens S, Boes M (2013) Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation. Oncoimmunology 2:e26403. doi: 10.4161\/onci.26403","journal-title":"Oncoimmunology"},{"key":"1749_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/clim.2001.5165","volume":"103","author":"AM Hohlbaum","year":"2002","unstructured":"Hohlbaum AM, Saff RR, Marshak-Rothstein A (2002) Fas-ligand\u2013iron fist or achilles\u2019 heel? Clin Immunol 103:1\u20136","journal-title":"Clin Immunol"},{"key":"1749_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/JCI31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"Lin WW, Karin M (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117:1175\u20131183. doi: 10.1172\/JCI31537","journal-title":"J Clin Invest"},{"key":"1749_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10555-010-9222-7","volume":"29","author":"SA Bergfeld","year":"2010","unstructured":"Bergfeld SA, DeClerck YA (2010) Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 29:249\u2013261. doi: 10.1007\/s10555-010-9222-7","journal-title":"Cancer Metastasis Rev"},{"key":"1749_CR15","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","volume":"102","author":"F Djouad","year":"2003","unstructured":"Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837\u20133844. doi: 10.1182\/blood-2003-04-1193","journal-title":"Blood"},{"key":"1749_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3324\/haematol.11240","volume":"92","author":"C Prevosto","year":"2007","unstructured":"Prevosto C, Zancolli M, Canevali P, Zocchi MR, Poggi A (2007) Generation of cd4+ or cd8+ regulatory t cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica 92:881\u2013888","journal-title":"Haematologica"},{"key":"1749_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","volume":"11","author":"HM Lazarus","year":"2005","unstructured":"Lazarus HM, Koc ON, Devine SM et al (2005) Cotransplantation of hla-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389\u2013398. doi: 10.1016\/j.bbmt.2005.02.001","journal-title":"Biol Blood Marrow Transplant"},{"key":"1749_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbmt.2009.11.006","volume":"16","author":"H Zhou","year":"2010","unstructured":"Zhou H, Guo M, Bian C, Sun Z, Yang Z, Zeng Y, Ai H, Zhao RC (2010) Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. Biol Blood Marrow Transplant 16:403\u2013412. doi: 10.1016\/j.bbmt.2009.11.006","journal-title":"Biol Blood Marrow Transplant"},{"key":"1749_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","volume":"25","author":"J Tolar","year":"2007","unstructured":"Tolar J, Nauta AJ, Osborn MJ et al (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25:371\u2013379. doi: 10.1634\/stemcells.2005-0620","journal-title":"Stem Cells"},{"key":"1749_CR20","doi-asserted-by":"publisher","first-page":"13159","DOI":"10.1073\/pnas.95.22.13159","volume":"95","author":"RP Leon","year":"1998","unstructured":"Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, Duke RC, DeGregori J (1998) Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci U S A 95:13159\u201313164","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1749_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2004.03.011","volume":"112","author":"JF Modiano","year":"2004","unstructured":"Modiano JF, Sun J, Lang J et al (2004) Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated t cells. Clin Immunol 112:54\u201365","journal-title":"Clin Immunol"},{"key":"1749_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.yexcr.2014.02.020","volume":"323","author":"JH Kim","year":"2014","unstructured":"Kim JH, Frantz AM, Anderson KL et al (2014) Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. Exp Cell Res 323:155\u2013164. doi: 10.1016\/j.yexcr.2014.02.020","journal-title":"Exp Cell Res"},{"key":"1749_CR23","doi-asserted-by":"publisher","first-page":"e55146","DOI":"10.1371\/journal.pone.0055146","volume":"8","author":"Y Ino","year":"2013","unstructured":"Ino Y, Yamazaki-Itoh R, Oguro S, Shimada K, Kosuge T, Zavada J, Kanai Y, Hiraoka N (2013) Arginase ii expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer. PLoS ONE 8:e55146. doi: 10.1371\/journal.pone.0055146","journal-title":"PLoS ONE"},{"key":"1749_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1746-1596-7-42","volume":"7","author":"AE Rizzardi","year":"2012","unstructured":"Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ, Schmechel SC (2012) Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol 7:42. doi: 10.1186\/1746-1596-7-42","journal-title":"Diagn Pathol"},{"key":"1749_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<573::AID-IJC12>3.0.CO;2-W","volume":"81","author":"M Ferrarini","year":"1999","unstructured":"Ferrarini M, Imro MA, Sciorati C, Heltai S, Protti MP, Pellicciari C, Rovere P, Manfredi AA, Rugarli C (1999) Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes. Int J Cancer 81:573\u2013579","journal-title":"Int J Cancer"},{"key":"1749_CR26","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1038\/sj.onc.1206399","volume":"22","author":"L Tourneur","year":"2003","unstructured":"Tourneur L, Mistou S, Michiels FM, Devauchelle V, Renia L, Feunteun J, Chiocchia G (2003) Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells. Oncogene 22:2795\u20132804. doi: 10.1038\/sj.onc.1206399","journal-title":"Oncogene"},{"key":"1749_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.tp.0000236098.13804.0b","volume":"82","author":"F Djouad","year":"2006","unstructured":"Djouad F, Bony C, Apparailly F, Louis-Plence P, Jorgensen C, Noel D (2006) Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 82:1060\u20131066. doi: 10.1097\/01.tp.0000236098.13804.0b","journal-title":"Transplantation"},{"key":"1749_CR28","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/stem.81","volume":"27","author":"H Wang","year":"2009","unstructured":"Wang H, Cao F, De A, Cao Y, Contag C, Gambhir SS, Wu JC, Chen X (2009) Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 27:1548\u20131558. doi: 10.1002\/stem.81","journal-title":"Stem Cells"},{"key":"1749_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3892\/or.2014.3264","volume":"32","author":"H Li","year":"2014","unstructured":"Li H, Feng Z, Tsang TC et al (2014) Fusion of hepg2 cells with mesenchymal stem cells increases cancerassociated and malignant properties: an in vivo metastasis model. Oncol Rep 32:539\u2013547. doi: 10.3892\/or.2014.3264","journal-title":"Oncol Rep"},{"key":"1749_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/ol.2014.2127","volume":"8","author":"P Zhang","year":"2014","unstructured":"Zhang P, Dong L, Long H, Yang TT, Zhou Y, Fan QY, Ma BA (2014) Homologous mesenchymal stem cells promote the emergence and growth of pulmonary metastases of the rat osteosarcoma cell line UMR-106. Oncol Lett 8:127\u2013132. doi: 10.3892\/ol.2014.2127","journal-title":"Oncol Lett"},{"key":"1749_CR31","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1038\/cddis.2014.263","volume":"5","author":"Q Zhu","year":"2014","unstructured":"Zhu Q, Zhang X, Zhang L et al (2014) The il-6-stat3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression. Cell Death Dis 5:e1295. doi: 10.1038\/cddis.2014.263","journal-title":"Cell Death Dis"},{"key":"1749_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","volume":"274","author":"M Hahne","year":"1996","unstructured":"Hahne M, Rimoldi D, Schroter M et al (1996) Melanoma cell expression of fas(apo-1\/cd95) ligand: implications for tumor immune escape. Science 274:1363\u20131366","journal-title":"Science"},{"key":"1749_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.184.3.1075","volume":"184","author":"J O\u2019Connell","year":"1996","unstructured":"O\u2019Connell J, O\u2019Sullivan GC, Collins JK, Shanahan F (1996) The fas counterattack: fas-mediated t cell killing by colon cancer cells expressing fas ligand. J Exp Med 184:1075\u20131082","journal-title":"J Exp Med"},{"key":"1749_CR34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V90.1.12","volume":"90","author":"A Villunger","year":"1997","unstructured":"Villunger A, Egle A, Marschitz I, Kos M, Bock G, Ludwig H, Geley S, Kofler R, Greil R (1997) Constitutive expression of Fas (apo-1\/cd95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood 90:12\u201320","journal-title":"Blood"},{"key":"1749_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/sj.cdd.4400477","volume":"6","author":"TE Hedlund","year":"1999","unstructured":"Hedlund TE, Meech SJ, Srikanth S, Kraft AS, Miller GJ, Schaack JB, Duke RC (1999) Adenovirus-mediated expression of fas ligand induces apoptosis of human prostate cancer cells. Cell Death Differ 6:175\u2013182. doi: 10.1038\/sj.cdd.4400477","journal-title":"Cell Death Differ"},{"key":"1749_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1006\/bbrc.1996.1669","volume":"228","author":"M Shimizu","year":"1996","unstructured":"Shimizu M, Yoshimoto T, Nagata S, Matsuzawa A (1996) A trial to kill tumor cells through fas (cd95)-mediated apoptosis in vivo. Biochem Biophys Res Commun 228:375\u2013379","journal-title":"Biochem Biophys Res Commun"},{"key":"1749_CR37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.intimp.2010.01.014","volume":"10","author":"S Pulavendran","year":"2010","unstructured":"Pulavendran S, Vignesh J, Rose C (2010) Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice. Int Immunopharmacol 10:513\u2013519. doi: 10.1016\/j.intimp.2010.01.014","journal-title":"Int Immunopharmacol"},{"key":"1749_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/scrt469","volume":"5","author":"Y Geng","year":"2014","unstructured":"Geng Y, Zhang L, Fu B et al (2014) Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of m2 macrophages. Stem Cell Res Therapy 5:80. doi: 10.1186\/scrt469","journal-title":"Stem Cell Res Therapy"},{"key":"1749_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.yexcr.2014.06.007","volume":"326","author":"KH Ryu","year":"2014","unstructured":"Ryu KH, Kim SY, Kim YR, Woo SY, Sung SH, Kim HS, Jung SC, Jo I, Park JW (2014) Tonsil-derived mesenchymal stem cells alleviate concanavalin a-induced acute liver injury. Exp Cell Res 326:143\u2013154. doi: 10.1016\/j.yexcr.2014.06.007","journal-title":"Exp Cell Res"},{"key":"1749_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10753-014-9954-6","volume":"38","author":"X Song","year":"2015","unstructured":"Song X, Xie S, Lu K, Wang C (2015) Mesenchymal stem cells alleviate experimental asthma by inducing polarization of alveolar macrophages. Inflammation 38:485\u2013492. doi: 10.1007\/s10753-014-9954-6","journal-title":"Inflammation"},{"key":"1749_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.imlet.2007.10.002","volume":"115","author":"K English","year":"2008","unstructured":"English K, Barry FP, Mahon BP (2008) Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 115:50\u201358","journal-title":"Immunol Lett"},{"key":"1749_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00262-012-1388-0","volume":"62","author":"G Chen","year":"2013","unstructured":"Chen G, Emens LA (2013) Chemoimmunotherapy: reengineering tumor immunity. Cancer Immunol Immunother 62:203\u2013216. doi: 10.1007\/s00262-012-1388-0","journal-title":"Cancer Immunol Immunother"},{"key":"1749_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3858\/emm.2009.41.5.035","volume":"41","author":"SH Yang","year":"2009","unstructured":"Yang SH, Park MJ, Yoon IH et al (2009) Soluble mediators from mesenchymal stem cells suppress t cell proliferation by inducing il-10. Exp Mol Med 41:315\u2013324. doi: 10.3858\/emm.2009.41.5.035","journal-title":"Exp Mol Med"},{"key":"1749_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/08820139.2011.619022","volume":"41","author":"YS Choi","year":"2012","unstructured":"Choi YS, Jeong JA, Lim DS (2012) Mesenchymal stem cell-mediated immature dendritic cells induce regulatory t cell-based immunosuppressive effect. Immunol Invest 41:214\u2013229. doi: 10.3109\/08820139.2011.619022","journal-title":"Immunol Invest"},{"key":"1749_CR45","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","volume":"37","author":"J Kim","year":"2009","unstructured":"Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37:1445\u20131453. doi: 10.1016\/j.exphem.2009.09.004","journal-title":"Exp Hematol"},{"key":"1749_CR46","doi-asserted-by":"publisher","first-page":"e9252","DOI":"10.1371\/journal.pone.0009252","volume":"5","author":"J Maggini","year":"2010","unstructured":"Maggini J, Mirkin G, Bognanni I et al (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 5:e9252. doi: 10.1371\/journal.pone.0009252","journal-title":"PLoS ONE"},{"key":"1749_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1751-553X.2007.00997.x","volume":"31","author":"A Nasef","year":"2009","unstructured":"Nasef A, Zhang YZ, Mazurier C et al (2009) Selected stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hematol 31:9\u201319. doi: 10.1111\/j.1751-553X.2007.00997.x","journal-title":"Int J Lab Hematol"},{"key":"1749_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D et al (2012) Mesenchymal-stem-cell-induced immunoregulation involves fas-ligand-\/fas-mediated t cell apoptosis. Cell Stem Cell 10:544\u2013555. doi: 10.1016\/j.stem.2012.03.007","journal-title":"Cell Stem Cell"},{"key":"1749_CR49","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.4049\/jimmunol.1301828","volume":"192","author":"R Chinnadurai","year":"2014","unstructured":"Chinnadurai R, Copland IB, Patel SR, Galipeau J (2014) Ido-independent suppression of t cell effector function by ifn-gamma-licensed human mesenchymal stromal cells. J Immunol. 192:1491\u20131501. doi: 10.4049\/jimmunol.1301828","journal-title":"J Immunol."},{"key":"1749_CR50","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/eji.201343668","volume":"44","author":"A Dorronsoro","year":"2014","unstructured":"Dorronsoro A, Ferrin I, Salcedo JM et al (2014) Human mesenchymal stromal cells modulate t-cell responses through TNF-alpha-mediated activation of NF-kappab. Eur J Immunol 44:480\u2013488. doi: 10.1002\/eji.201343668","journal-title":"Eur J Immunol"},{"key":"1749_CR51","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/j.1582-4934.2010.01215.x","volume":"15","author":"Z Han","year":"2011","unstructured":"Han Z, Tian Z, Lv G et al (2011) Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J Cell Mol Med 15:2343\u20132352. doi: 10.1111\/j.1582-4934.2010.01215.x","journal-title":"J Cell Mol Med"},{"key":"1749_CR52","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.1195300","volume":"330","author":"M Kraman","year":"2010","unstructured":"Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT (2010) Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 330:827\u2013830. doi: 10.1126\/science.1195300","journal-title":"Science"},{"key":"1749_CR53","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","volume":"11","author":"G Ren","year":"2012","unstructured":"Ren G, Zhao X, Wang Y et al (2012) Ccr2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by tnfalpha. Cell Stem Cell 11:812\u2013824. doi: 10.1016\/j.stem.2012.08.013","journal-title":"Cell Stem Cell"},{"key":"1749_CR54","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-13-1656","volume":"74","author":"W Ling","year":"2014","unstructured":"Ling W, Zhang J, Yuan Z et al (2014) Mesenchymal stem cells use ido to regulate immunity in tumor microenvironment. Cancer Res 74:1576\u20131587. doi: 10.1158\/0008-5472.CAN-13-1656","journal-title":"Cancer Res"},{"key":"1749_CR55","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1182\/blood-2014-03-453217","volume":"124","author":"P Scapini","year":"2014","unstructured":"Scapini P, Cassatella MA (2014) Social networking of human neutrophils within the immune system. Blood 124:710\u2013719. doi: 10.1182\/blood-2014-03-453217","journal-title":"Blood"},{"key":"1749_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348:74\u201380. doi: 10.1126\/science.aaa6204","journal-title":"Science"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1749-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1749-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T22:27:10Z","timestamp":1691879230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1749-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1749-6","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]},"assertion":[{"value":"5 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}